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ABSTRACT 
Gut microbial regulation of bile acid metabolism and 
signaling 
Sama Islam Sayin 
Department of Molecular and Clinical Medicine, 
Institute of Medicine 
Sahlgrenska Academy at University of Gothenburg, Sweden 
The collection of microbes in our gastrointestinal tract, the gut microbiota, is an environmental factor 
that has profound impact on host health and disease. Bile acids are endogenous cholesterol-derived 
molecules that can be modified by the gut microbiota and function as signaling molecules in 
regulation of host metabolic processes. This thesis investigates the role of the gut microbiota on bile 
acid metabolism and signaling by comparing mice that lack microbiota with their conventionally-
raised counterparts.  
We found that the gut microbiota regulates bile acid metabolism at several levels, including 
proportionalities of individual bile acid species and expression of genes involved in bile acid 
homeostasis. Specifically, the gut microbiota decreased levels of mouse primary bile acid tauro-beta-
muricholic acid (T-βMCA), which we identified as an antagonist of the nuclear receptor farnesoid-x-
receptor (FXR).  FXR mediates negative feedback regulation of bile acid homeostasis, as well as 
regulation of several physiological processes. Hence, we identified the molecular mechanism behind 
microbial regulation of bile acid homeostasis as T-βMCA mediated inhibition of FXR activity. Since 
humans lack T-βMCA, this thesis plays an important role in explaining the existing discrepancies 
between mouse and human studies targeting FXR for treating gastrointestinal diseases. Furthermore, 
in order to better understand the effect of the microbiota on FXR signaling, we re-derived mice that 
lacked functional FXR as germ-free and mapped microbial regulation of genes through FXR.  We 
found that the microbiota can regulate expression of FXR target genes through direct FXR binding to 
promoters in the intestine, while protein-protein interactions between FXR and other co-regulators 
are likely regulated in the liver.  
In conclusion, this study establishes the microbiota as a key player in bile acid metabolism and FXR 
signaling in the liver and the intestine. The findings from this thesis implicate the microbiota as an 
important factor that needs to be taken into consideration in treating gastrointestinal diseases by 
targeting bile-acid mediated FXR signaling.  
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